Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trial
43Citations signalées
22Institutions associées
12Pays d’affiliation
Résumé indisponible dans les métadonnées reçues.
Institutions
Kenya Medical Research InstituteInfectious Diseases Research CollaborationUganda Virus Research InstituteInstitut de Recherche en Sciences de la SantéInstitut Pasteur de Côte d'IvoireMaesot General HospitalRajendra Institute of Medical SciencesUniversität HamburgCentre de Recherche Médicales de LambarénéUniversity Medical Center Hamburg-EppendorfBernhard Nocht Institute for Tropical MedicineUnited States Army Medical Research Directorate - AfricaNational Institute of Malaria ResearchMedicines for Malaria VentureNovartis (Switzerland)Novartis (India)Novartis (United States)University of BamakoMalaria Research and Training CenterAmsterdam University Medical CentersUniversity of TübingenUniversity of Amsterdam
Sujets associés
Malaria Research and ControlCancer and biochemical researchDiverse Scientific Research Studies